Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Leadership & People

Set Alert for Leadership & People

Executives On The Move: UCB, LAVA Therapeutics and More

Recent executive moves in the industry include C-suite changes at Arcus Biosciences and UCB. Meanwhile, new directors were appointed at Arovella Therapeutics and LAVA Therapeutics.

Executive Changes Leadership

Executives On The Move: Changes At Albireo Pharma, AbbVie And Lundbeck

Recent executive moves in the industry include C-suite changes at Albireo Pharma, Aptevo Therapeutics and AbbVie. Meanwhile, new directors were appointed at Amarin and Oculis Holding.

Executive Changes Leadership

Executives On The Move: Avidity Biosciences, Exicure and More

Recent executive moves in the industry include C-suite changes at Avidity Biosciences and BioAtla. Meanwhile, new directors were appointed at Exicure and Alimera Sciences.

Executive Changes Leadership

No Slowdown From Bayer On Business Development Front

“We're looking at opportunities almost on a weekly basis,” Bayer’s pharma chief Stefan Oelrich told Scrip as the German major posted a solid set of financials for the fourth quarter.

Sales & Earnings Business Strategies

Viatris To Bring In Plenty Of Brand Knowledge With New CEO Smith

Only three months after joining Viatris’ board of directors, Scott Smith, famed for spearheading Celgene’s successful and lucrative Inflammation and Immunology division, has been announced as the company’s new CEO, beginning 1 April.

Executive Changes Companies

Executives On The Move: Sandoz, Clyra Medical Technologies, IRLAB Therapeutics and More

Recent executive moves in the industry include C-suite changes IRLAB Therapeutics and Mercy Bioanalytics. Meanwhile, new directors were appointed at Clyra Medical Technologies and Jasper Therapeutics, while Sandoz has a new chairman-designate.

Executive Changes Leadership

Quick Listen: Scrip's Five Must-Know Things

In this week's podcast version of Five Must-Know Things: Leqembi bodes well for Biogen; AbbVie predicts US Humira erosion; Sanofi’s R&D chief moves on; Roche’s ophthalmology plans; and Scrip Asks what 2023 holds for AI in pharma.

Commercial Executive Changes

Bausch + Lomb Taps A Familiar Face, Brent Saunders, As Next CEO

Saunders will oversee the eye specialist, returning to the firm where he got his start as a chief executive before earning a reputation as one of industry’s biggest dealmakers.

Leadership Companies

J&J-Bound Reed Reaches End Of The Road As Sanofi R&D Chief

The French drugmaker has begun an external and internal search to succeed John Reed who is heading for Johnson & Johnson after an up-and-down five years as Sanofi’s R&D chief.

Executive Changes Business Strategies

Business Development Remains Top Priority For Ipsen

CEO David Loew tells Scrip that Ipsen’s prodigious dealmaking over the past couple of years is set to continue, on top of the acquisition of Albireo announced last month.

Sales & Earnings Business Strategies

Executives On The Move: Medexus Pharmaceuticals, Alliance Pharma and More

Recent executive moves in the industry include C-suite changes Alliance Pharma and Race Oncology. Meanwhile, new directors were appointed at Medexus Pharmaceuticals and Scancell Holdings.

Executive Changes Leadership

For Some Biotechs, IRA Remains Intangible – For Now

Some biotech leaders say IRA policies don’t feel consequential yet, though small companies could face impacts from R&D and M&A decision making at big pharmas.

Deals Medicare
See All
UsernamePublicRestriction

Register